Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Psychosocial Effects of COVID-19 Measures on (Pre-)Dementia Patients During Second Lockdown.
Bakker ED, van Maurik IS, Mank A, Zwan MD, Waterink L, van den Buuse S, van den Broeke JR, Gillissen F, van de Beek M, Lemstra E, van den Bosch KA, van Leeuwenstijn M, Bouwman FH, Scheltens P, van der Flier WM. Bakker ED, et al. Among authors: zwan md. J Alzheimers Dis. 2022;86(2):931-939. doi: 10.3233/JAD-215342. J Alzheimers Dis. 2022. PMID: 35034903
The effect of amyloid pathology and glucose metabolism on cortical volume loss over time in Alzheimer's disease.
Adriaanse SM, van Dijk KR, Ossenkoppele R, Reuter M, Tolboom N, Zwan MD, Yaqub M, Boellaard R, Windhorst AD, van der Flier WM, Scheltens P, Lammertsma AA, Barkhof F, van Berckel BN. Adriaanse SM, et al. Among authors: zwan md. Eur J Nucl Med Mol Imaging. 2014 Jun;41(6):1190-8. doi: 10.1007/s00259-014-2704-z. Epub 2014 Mar 11. Eur J Nucl Med Mol Imaging. 2014. PMID: 24615466 Free PMC article.
Long-term effects of amyloid, hypometabolism, and atrophy on neuropsychological functions.
Ossenkoppele R, van der Flier WM, Verfaillie SC, Vrenken H, Versteeg A, van Schijndel RA, Sikkes SA, Twisk J, Adriaanse SM, Zwan MD, Boellaard R, Windhorst AD, Barkhof F, Scheltens P, Lammertsma AA, van Berckel BN. Ossenkoppele R, et al. Among authors: zwan md. Neurology. 2014 May 20;82(20):1768-75. doi: 10.1212/WNL.0000000000000432. Epub 2014 Apr 18. Neurology. 2014. PMID: 24748672
Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis.
Ossenkoppele R, Jansen WJ, Rabinovici GD, Knol DL, van der Flier WM, van Berckel BN, Scheltens P, Visser PJ; Amyloid PET Study Group; Verfaillie SC, Zwan MD, Adriaanse SM, Lammertsma AA, Barkhof F, Jagust WJ, Miller BL, Rosen HJ, Landau SM, Villemagne VL, Rowe CC, Lee DY, Na DL, Seo SW, Sarazin M, Roe CM, Sabri O, Barthel H, Koglin N, Hodges J, Leyton CE, Vandenberghe R, van Laere K, Drzezga A, Forster S, Grimmer T, Sánchez-Juan P, Carril JM, Mok V, Camus V, Klunk WE, Cohen AD, Meyer PT, Hellwig S, Newberg A, Frederiksen KS, Fleisher AS, Mintun MA, Wolk DA, Nordberg A, Rinne JO, Chételat G, Lleo A, Blesa R, Fortea J, Madsen K, Rodrigue KM, Brooks DJ. Ossenkoppele R, et al. Among authors: zwan md. JAMA. 2015 May 19;313(19):1939-49. doi: 10.1001/jama.2015.4669. JAMA. 2015. PMID: 25988463 Free PMC article.
Use of amyloid-PET to determine cutpoints for CSF markers: A multicenter study.
Zwan MD, Rinne JO, Hasselbalch SG, Nordberg A, Lleó A, Herukka SK, Soininen H, Law I, Bahl JM, Carter SF, Fortea J, Blesa R, Teunissen CE, Bouwman FH, van Berckel BN, Visser PJ. Zwan MD, et al. Neurology. 2016 Jan 5;86(1):50-8. doi: 10.1212/WNL.0000000000002081. Epub 2015 Oct 14. Neurology. 2016. PMID: 26468410 Free PMC article.
56 results